Pleco Therapeutics’ mission is to demonstrate the market value and therapeutic potential of our proprietary Plecoid™ products through an initial focus on treatments for orphan cancers. Thereafter we can expand our scalable product platform for the treatment of other cancers as well as neurodegenerative disorders where aberrant metal patterns have been shown to play a role.
Our current pre-clinical development programs f...
Pleco Therapeutics’ mission is to demonstrate the market value and therapeutic potential of our proprietary Plecoid™ products through an initial focus on treatments for orphan cancers. Thereafter we can expand our scalable product platform for the treatment of other cancers as well as neurodegenerative disorders where aberrant metal patterns have been shown to play a role.
Our current pre-clinical development programs focus on the development of treatments for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer. Both diseases carry a poor prognosis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.